Investigated for use/treatment in transplant (rejection).

Investigated for use/treatment in obesity.

Investigated for use/treatment in constipation, gastrointestinal diseases and disorders (miscellaneous), gastroparesis, and irritable bowel syndrome (IBS).

Investigated for use/treatment in solid tumors.

Investigated for use/treatment in muscular dystrophy.

Investigated for use/treatment in thrombocytopenia.

Investigated for use/treatment in hepatitis (viral, C).

Investigated for use/treatment in acromegaly and cancer/tumors (unspecified).

Investigated for use/treatment in leukemia (myeloid), myelodysplastic syndrome, and solid tumors.

Investigated for use/treatment in neurologic disorders.

Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors.

Investigated for use/treatment in solid tumors.

Currently in Phase III investigation for treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma in patients who have failed two prior lines of therapy. Presently, no...

Indicated in combination with acetylsalicylic acid (ASA) to prevent atherothrombotic events in patients with acute coronary syndrome (ACS) who are to be managed with percutaneous ...

Lacosamide is indicated for adjunctive therapy for partial onset seizures in patients with epilepsy over 17 years old. Injection is indicated for short term use when oral therapy ...

Rivaroxaban is indicated for the prevention of venous thromboembolic events (VTE) in patients who have undergone total hips replacements and total knee replacement surgery; ...

Treatment of erectile dysfunction in males.

Investigated for use/treatment in erectile dysfunction and hypertension.

Used to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. Also investigated for ...

For the treatment of renal cell carcinoma (RCC). Also investigated for use/treatment in breast cancer, lymphoma (unspecified), rheumatoid arthritis, and multiple myeloma.